In a 44-year-old woman with chronic anxiety and intermittent skin symptoms despite allergy immunotherapy, what additional physical conditions should be evaluated to rule out causes of her anxiety and dermatologic manifestations?

Physical Conditions to Rule Out in a 44-Year-Old Woman with Chronic Anxiety and Intermittent Skin Symptoms

You must rule out thyroid disease and substance/medication-induced causes first, as these are the most critical alternative causes of anxiety that require specific diagnostic evaluation before confirming a primary anxiety disorder. 1

Priority Medical Workup

Essential Laboratory Testing

The guidelines explicitly state that diagnosis of an anxiety disorder requires ruling out alternative causes, particularly:

• Thyroid function tests (TSH, free T4): Hyperthyroidism is a well-established medical cause of anxiety symptoms with panic attacks 1, 2
• Comprehensive metabolic panel: To assess for hypoglycemia, electrolyte disturbances 2
• Complete blood count: To evaluate for anemia or other hematologic conditions

Medication and Substance Review

Conduct a thorough review of:

• All current medications (prescription and over-the-counter)
• Caffeine intake (caffeinism can mimic anxiety) 2
• Alcohol use patterns
• Any stimulant medications or supplements
• Recent medication changes that coincide with symptom onset

Additional Medical Conditions to Consider

Given her dermatologic symptoms alongside anxiety, evaluate for:

Endocrine Disorders

• Pheochromocytoma: Though rare, presents with episodic anxiety, panic attacks, and flushing 2
• Hypoglycemic episodes: Can cause anxiety-like symptoms 2
• Diabetes: Associated with both anxiety and skin manifestations 2

Cardiovascular Assessment

• Cardiac arrhythmias: Can present as panic-like episodes 2
• Cardiac valvular disease: May cause anxiety symptoms 2

Consider ECG if patient describes palpitations, chest discomfort, or if panic attacks include prominent cardiovascular symptoms.

Dermatologic-Psychiatric Interface

The evidence shows a strong bidirectional relationship between skin disease and anxiety. Adults with atopic dermatitis have 1.17 times higher risk of developing new anxiety 3, and anxiety/depression are present in 24.5% and 19.8% of AD patients respectively 4.

Specific considerations:

• Atopic dermatitis severity: Correlates with anxiety burden through inflammatory cytokines (IL-6, TNF-α) 5
• Sleep disorders: Present in both anxiety and dermatologic conditions, creating a reinforcing cycle 4
• Chronic urticaria: Has strong association with AD (OR 9.92) and may potentiate itch-scratch-anxiety cycle 6

Autoimmune and Inflammatory Conditions

• Systemic lupus erythematosus: Can present with both skin manifestations and neuropsychiatric symptoms 2
• Allergic reactions: Beyond her known allergies, assess for new triggers 2

Other Physical Causes

• Chronic pain conditions: Associated with both anxiety and dermatologic symptoms 2
• Asthma: Significantly associated with depression in AD patients (OR 2.208) 4
• Allergic rhinitis: Associated with anxiety in AD patients (OR 2.052) 4

Psychiatric Comorbidity Screening

Screen for depression using validated tools, as 56% of patients with anxiety disorders have comorbid major depressive disorder 1. The guidelines recommend:

• GAD-7 scale: Score ≥9 indicates likely generalized anxiety disorder (sensitivity and specificity for diagnosis) 7
• Depression screening: Use PHQ-9 or similar validated instrument 1
• Assess suicide risk: Anxiety disorders are significantly associated with suicide attempts 1

Clinical Pitfalls to Avoid

1. Don't assume skin symptoms are purely allergic: The waxing-waning pattern of both anxiety and skin symptoms suggests possible psychodermatologic interaction 6, 3

2. Don't overlook sleep disorders: These are independent risk factors for both anxiety (OR 2.013) and depression (OR 2.245) in dermatologic patients 4

3. Don't miss medication-induced causes: Allergy shots and dermatologic treatments can have psychiatric side effects

4. Don't ignore the inflammatory connection: Elevated IL-6 and TNF-α from skin inflammation may directly contribute to anxiety symptoms through neuroimmune pathways 5, 8

Structured Diagnostic Approach

1. Immediate laboratory workup: Thyroid function, metabolic panel, CBC
2. Medication/substance review: Complete list with timing relative to symptoms
3. Cardiovascular assessment: ECG if indicated by symptoms
4. Validated anxiety screening: GAD-7 (score ≥9 requires further evaluation) 7
5. Depression screening: Given 56% comorbidity rate 1
6. Dermatologic severity assessment: SCORAD index correlates with anxiety burden 4
7. Sleep quality evaluation: Independent risk factor requiring specific attention 4

Once medical causes are excluded, formal psychiatric evaluation is warranted to establish specific anxiety disorder diagnosis per DSM-5 criteria and initiate evidence-based treatment (CBT as first-line, SSRIs/SNRIs as secondary) 1.